Tsurumura T and Tsuge H |
Substrate selectivity of bacterial monoacylglycerol lipase based on crystal structure. |
2014 |
J. Struct. Funct. Genomics |
pmid:24894647
|
Navarria A et al. |
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. |
2014 |
Pharmacol. Res. |
pmid:24861565
|
Oleson EB et al. |
Cannabinoid receptor activation shifts temporally engendered patterns of dopamine release. |
2014 |
Neuropsychopharmacology |
pmid:24345819
|
Brantl SA et al. |
Mechanism of platelet activation induced by endocannabinoids in blood and plasma. |
2014 |
Platelets |
pmid:23789792
|
Pascual AC et al. |
Aging modifies the enzymatic activities involved in 2-arachidonoylglycerol metabolism. |
2013 Mar-Apr |
Biofactors |
pmid:23281018
|
Fonseca BM et al. |
Endogenous cannabinoids revisited: a biochemistry perspective. |
2013 Apr-May |
Prostaglandins Other Lipid Mediat. |
pmid:23474290
|
Jäntti MH et al. |
Autocrine endocannabinoid signaling through CB1 receptors potentiates OX1 orexin receptor signaling. |
2013 |
Mol. Pharmacol. |
pmid:23233488
|
Su LD et al. |
Retrograde cPLA2α/arachidonic acid/2-AG signaling is essential for cerebellar depolarization-induced suppression of excitation and long-term potentiation. |
2013 |
Cerebellum |
pmid:23307660
|
Keimpema E et al. |
Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:23319656
|
Shimizu T et al. |
Stimulatory and inhibitory roles of brain 2-arachidonoylglycerol in bombesin-induced central activation of adrenomedullary outflow in rats. |
2013 |
J. Pharmacol. Sci. |
pmid:23386378
|
Alhouayek M et al. |
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24101490
|
Citraro R et al. |
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. |
2013 |
Neuropharmacology |
pmid:23206503
|
Frazier CJ |
Preformed vs. on-demand: molecular economics of endocannabinoid signalling. |
2013 |
J. Physiol. (Lond.) |
pmid:24085490
|
Descalzi F et al. |
Platelet-rich plasma exerts antinociceptive activity by a peripheral endocannabinoid-related mechanism. |
2013 |
Tissue Eng Part A |
pmid:23578218
|
Bisogno T et al. |
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects. |
2013 |
Br. J. Pharmacol. |
pmid:23072382
|
Zygmunt PM et al. |
Monoacylglycerols activate TRPV1--a link between phospholipase C and TRPV1. |
2013 |
PLoS ONE |
pmid:24312564
|
Hill MN et al. |
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. |
2013 |
Psychoneuroendocrinology |
pmid:24035186
|
Bernabò N et al. |
Systems biology analysis of the endocannabinoid system reveals a scale-free network with distinct roles for anandamide and 2-arachidonoylglycerol. |
2013 |
OMICS |
pmid:24117401
|
Malenczyk K et al. |
CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin release. |
2013 |
J. Biol. Chem. |
pmid:24089517
|
Brocato B et al. |
Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity. |
2013 |
Placenta |
pmid:24008071
|